STRAX secured a third tranche under the existing loan agreement with Proventus Capital Partners (PCP), dedicated to the health & wellness category, in the amount of USD 20 million. Initially STRAX will draw down USD 5 million under the dedicated tranche to finance existing orders. STRAX will make further draw-downs when needed to secure future orders. The third tranche from Proventus Capital Partners is for a term of 18 months and the full amount is denominated in USD. The loan will carry a Euribor +7.5% interest rate, in line with current market pricing, as well as the average financing costs currently paid.